I-MED Pharma USA Announces Michelle Schnabel as VP Business Development
November 09, 2021 11:00 ET
|
I-MED Pharma
MONTREAL, Nov. 09, 2021 (GLOBE NEWSWIRE) -- With the recent expansion into the United States, I-MED Pharma USA is proud to announce the appointment of Michelle Schnabel to the role of VP Business...
I-MED Pharma USA Announces Brent Jones as Chief Commercial Officer
November 08, 2021 11:00 ET
|
I-MED Pharma
MONTREAL, Nov. 08, 2021 (GLOBE NEWSWIRE) -- With the recent expansion into the United States, I-MED Pharma USA is proud to announce the appointment of Brent Jones to Chief Commercial Officer...
I-MED Pharma Set to Launch Its Innovative Dry Eye Product Portfolio in the U.S.A.
November 05, 2021 11:00 ET
|
I-MED Pharma
MONTREAL, Nov. 05, 2021 (GLOBE NEWSWIRE) -- I-MED Pharma USA is bringing the world’s most innovative dry eye product portfolio to the U.S. market. Their uniquely formulated line of ocular surface...
AXIM Biotechnologies Appoints Clinical Research and DED Expert Dr. Michael E. Stern to its Medical Advisory Board
November 02, 2021 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” or “the Company”), an international healthcare solutions company targeting oncological,...
United Market Study of Dry Eye Sufferers 2021: Focus on Self-diagnosed and Physician-diagnosed Dry Eye, Detailing Symptoms, Severity and Treatment, Among Other Topics
November 02, 2021 04:53 ET
|
Research and Markets
Dublin, Nov. 02, 2021 (GLOBE NEWSWIRE) -- The "The 2021 Study of the U.S Market of Dry Eye Sufferers " report has been added to ResearchAndMarkets.com's offering. The 2021 Study of Dry Eye...
AXIM Biotechnologies Appoints Dry Eye Disease Expert and Accomplished Optometrist Dr. Kelly K. Nichols to its Medical Advisory Board
October 20, 2021 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Oct. 20, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” or “the Company”), an international healthcare solutions company targeting oncological,...
Silicon Valley Veteran Scott McNealy Joins EyecareLive's Advisory Board
October 12, 2021 09:00 ET
|
EyecareLive
SANTA CLARA, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- EyecareLive, a digital eye care platform and a telehealth services provider today announced that Silicon Valley veteran Scott McNealy has...
AXIM® Biotechnologies Appoints Leading US Ophthalmic Surgeon and Researcher Dr. Henry D. Perry to its Medical Advisory Board
October 11, 2021 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Oct. 11, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” or “the Company”), an international healthcare solutions company targeting oncological,...
Insights on the Ophthalmic Packaging Global Market to 2028 - Increasing Prevalence of Ocular Disorders is Driving Growth
September 30, 2021 04:18 ET
|
Research and Markets
Dublin, Sept. 30, 2021 (GLOBE NEWSWIRE) -- The "Ophthalmic Packaging Market Size, Share & Trends Analysis Report By Dose (Single Dose, Multi Dose), By Type (OTC, Prescription), By Material...
AXIM® Biotechnologies Appoints Joseph Tauber, MD, Chief Medical Officer and Chairman of its Medical Advisory Board
September 21, 2021 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” or “the Company”), an international healthcare solutions company targeting oncological,...